A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)

Trial Profile

A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 21 Jun 2018

At a glance

  • Drugs Cytomegalovirus immune globulin (Primary)
  • Indications Cytomegalovirus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Jun 2018 Planned primary completion date changed from 1 May 2018 to 1 Nov 2018.
    • 12 Jun 2018 Status changed from recruiting to active, no longer recruiting.
    • 25 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top